Answers are grounded in this paper and cite their sources.
Microcystin-LR (MCLR) is a hepatotoxin that has been connected to development of metabolic dysfunction-associated steatotic liver disease (MASLD) and hepatocellular carcinoma, but the hepatotoxic effect of single versus repeated MCLR exposure in pre-existing MASLD is not known. Understanding how a single exposure versus repeated exposures modulate liver physiology can provide insight into risks associated with different exposure patterns. Sprague Dawley rats were fed a control diet or a high-fat, high-cholesterol (HFHC) diet and administered either single or repeated MCLR exposure(s). Necrosis was more prominent after a single MCLR exposure compared to repeated exposure in both diet groups. Inflammation was also more prominent in the control diet group after a single MCLR exposure compared to repeated exposure, whereas it was equally severe after both exposure scenarios in the HFHC diet group. Repeated MCLR exposure caused a larger number of differentially expressed genes compared to a single exposure in both diet groups, although more genes were differentially expressed in the control diet than in the HFHC diet. KEGG Pathways in cancer and phosphatidylinositol 3-kinase (PI3K)-Akt signaling pathway were two pathways with the most upregulated genes in both diet groups after repeated MCLR exposure. Follow-up protein expression analysis confirmed activated Akt and increased c-JUN and cyclin D1 protein levels. The expression of β-catenin increased after repeated MCLR exposure only in the HFHC diet group, suggesting this important cell growth pathway may be activated by MCLR specifically in animals with pre-existing liver disease. This study highlights the differential impact of single versus repeated MCLR on liver pathology in healthy and MASLD conditions.
No takes yet. Share an insight, caveat, or question.
Ikumawoyi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: